1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Tinnitus: new trials by email Literature Review of Tinnitus trials Research Report on Tinnitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury DMSO-based otic solution with betahistine, dexamethasone, and lidocaine, DMSO-based transdermal cream with levocarnitine and N-acetylcysteine - Tinnitus | Phase 2 | Enrolling by invitation | Leading Edge Clinic | 20 | 2026-05-15 | 2026-05-13 |
Post-Acute COVID-19 Syndrome (1)
COVID-19 (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Ear Diseases (1) · Hearing Disorders (1) · Infections (1) · Lung Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nidovirales Infections (1) · Otorhinolaryngologic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Acetylcysteine (1) · Betahistine (1) · Carnitine (1) · Dexamethasone (1) · Lidocaine (1)
United States (1)